Tricuspid valve repair for severe leakage
Part of Heart & circulation clinical trials.
This trial tests a new device to fix a leaky tricuspid valve in the heart, which can cause symptoms like swelling and shortness of breath. The goal is to see if the device helps people who still have symptoms despite taking medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have severe tricuspid regurgitation (leaky valve) and still have symptoms despite taking heart medications.
- A team of heart doctors at the study site decides you are a good candidate for this procedure.
- You do not already have a tricuspid valve device implanted.
- You do not have heart anatomy that makes the procedure unsafe.
- You do not need urgent surgery for another heart problem.
- Your heart's pumping function (ejection fraction) is at least 25%.
- You are expected to live at least one more year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This trial tests a new catheter-based replacement for the tricuspid valve, which controls blood flow from the body into the heart. It aims to help people with severe tricuspid regurgitation (a leaky valve) who still have symptoms despite medication.
This trial tests a new, less-invasive device called 'Pivot Extend' for people with a severe leaky tricuspid valve (tricuspid regurgitation) who still have symptoms despite taking medicines. The goal is to see if the device can safely help reduce the leak and improve symptoms.
This trial tests a new robotic catheter procedure to repair a leaky tricuspid valve (the valve on the right side of your heart). Instead of open-heart surgery, doctors thread a tiny device through a vein in your neck to fix the valve. It may be an option if you have severe leaking and your heart team thinks surgery is too risky for you.
This trial tests a new device called the Medtronic Intrepid TTVR system to replace the tricuspid valve in people with severe tricuspid regurgitation (leaky valve). It aims to see if the device can safely and effectively fix the leak and improve symptoms.
This trial tests a catheter-based procedure (done through the blood vessels) to repair a severely leaky tricuspid valve. It may help people with symptoms or past hospitalizations from tricuspid valve leakage who are higher-risk for standard surgery.
Hear when a new Tricuspid Regurgitation (TR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.